| GUEST EDITORIAL
International Journal of Aesthetic and Anti-Ageing Medicine Informa Healthcare, 119 Farringdon Road, London, EC1R 3DA, UK
www.informahealthcare.com ISSN 2159-8908 (print) ISSN 2159-8916 (online)
Managing Editor Rosalind Hill
rosalind.hill@informa.com
Sub-Editor Balraj Juttla
balraj.juttla@informa.com
Publisher Simon Percival +44(0)20 7017 4060
simon.percival@
informa.com
European Sales Manager Mat Eaton +44(0)20 7017 4315
mat.eaton@informa.com
Business Development Manager NA Meg McNeel +1 (212) 520 2745
meg.mcneel@
informausa.com
Senior Marketing Executive Susie Comben
susie.comben@
informa.com
Marketing Assistant Rachel Scott
rachel.scott@
informa.com
Production Editor John Oliver
john.oliver@informa.com
Director of Audience Development Nora Pastenkos
nora.pastenkos@
informausa.com
Managing Director Nick Del Rio
nick.delrio@
informausa.com
Web Designer/Producer Marcus Hurley +44 (0)20 7017 4252
marcus.hurley@
informa.com
Art Director David ‘Spike’ McCormack
spike@spikedesigns.co.uk
Production & Ads Department
primeadverts@informa.com
Please send your manuscripts and press releases to:
rosalind.hill@informa.com
All submitted manuscripts are evaluated on the basis of scientific quality, originality, appropriateness, contribution to the field and style. Suitable manuscripts are subject to peer-review. Manuscripts and accompanying files should be prepared in accordance with our Author Guidelines, which are available via
www.prime-journal.com.
All content © 2013 Informa UK Ltd Images ©
Shutterstock.com, unless otherwise stated
W
HEN I STARTED WORKING IN THE COSMETIC INDUSTRY IN 2006, I WAS struck by the lack of regulation to protect the consumer (particularly in Britain). Later that year there was talk about introducing some proper legislation to protect consumers and that seemed to me, at the time, the correct action. There was an initial postponing of the introduction (put back to April 2007) and then as that deadline passed no real positive action.
Since then, and despite the outstanding campaigning and hard work on behalf of many of the
responsible people and organisations in the industry, the sector remains largely unregulated and therefore a potential minefield for UK consumers. These consumers are rightly excited at the possibility of having a treatment that genuinely transforms their life, but are unaware or unclear as to how to ensure they get the best treatments, undertaken by the best practitioners, and in an appropriate environment. I was hopeful but cautious last year when I was made aware of the Sir Bruce Keogh review. The
independent review committee into cosmetic interventions, announced in April, has set out how it would like to see the sector better regulated, practitioners better trained, some regulation of premises, and people having proper redress if things go wrong. These recommendations have been made to the UK Department of Health (DH), who I hope accept them formally this summer and implement during the remainder of 2013. The key elements the review group feel would contribute to a successful and safe industry include: making all dermal fillers prescription only; ensuring all practitioners are properly qualified for all procedures offered (including those offering breast enlargement to injectables); and an ombudsman to oversee all private healthcare — including cosmetic procedures — to assist those who have been treated poorly. The review reported that, despite the popularity of non-surgical procedures like BOTOX®, dermal
fillers or laser hair removal — which account for nine out of 10 procedures in the UK — there is almost no regulation. This is despite the fact that they can have major, permanent effects on people’s health and wellbeing. I believe that this clarifies the need for everyone to consider these treatments as health based, and not simply extensions of the beauty market. This is a critical distinction that we wholly support. The review committee have focused their recommendations on invasive procedures and injectables.
They have also mentioned lasers, the need for clinical professionals overseeing treatments, and a register for premises. This is very good news for the public; however, whether this is picked up by the DH remains to be seen. We are actively lobbying now for the inclusion of lasers in the recommendations. Clearly there is still much work to be done, but we have to believe that finally we have a report that
puts the needs of the patient at the heart of its recommendations and if properly implemented, will allow patients to realise that they can enjoy the benefits of life-changing treatments safe in the knowledge that the industry is appropriately governed and regulated.
Andy Randall Managing Director, sk:n Ltd, UK
PRIME JOURNAL EDITORIAL BOARD BOARD MEMBER SPECIALISM
Dr Claude Dalle
Dr Wilmar Accursio Dr Ashraf Badawi
Anti-ageing & aesth. medicine France Endocrinology Dermatology
Plastic surgery
Cosmetic Dermatology Oculoplastic surgery Maxillofacial surgery
Dr Christophe de Jaeger Geriatrics Dr Jacques Dequesne Prof Ilaria Ghersetich Dr Kate Goldie
Dr Monika Golkova Prof Eckart Haneke Dr Steven Hopping
Dr Marina Landau
Anti-ageing medicine Gynaecology
Dermatology
Aesthetic dermatology Neurology
Dermatology Plastic surgery
Prof Andreas Katsambas Dermatology Dr Mario Krause Dr David Lai
Anti-ageing medicine Anti-ageing medicine Dermatology
USA
COUNTRY Brazil
Dr Janethy Balakrishnan Aesthetic & anti-ageing medicine Malaysia Dr Lakhdar Belhaouari Dr Anthony Benedetto Dr Philippe Berros Dr Dario Bertossi Dr Pierre Bouhanna Dr Fahd Benslimane Prof Wayne Carey
Monaco Italy
Dermatology – Hair surgery Plastic Surgery Dermatology
Dr Claude Chauchard France
Morocco Canada France France France Italy UK
Czech Republic Germany USA
Greece Germany
Hong Kong Israel
Egypt & Canada France
BOARD MEMBER SPECIALISM Dr Gustavo Leibaschoff
Dr Sohail Mansoor Prof Leonardo Marini Dr Sly Nedic
Cosmetic Surgery Dermatology Dermatology
Prof Dr Martino Neumann Dermatology & Venereology Prof Daniel Pella
Cardiology
Dr Chariya Petchngaovilai Dermatology Prof Ascanio Polimeni Dr Herve Raspaldo
Dr Christopher Rowland-Payne Dermatology Dr Neil Sadick
Dr Hema Sundaram Dr Pakpilai Thavisin Dr Patrick Treacy Dr Mario Trelles Dr Ines Verner Dr Octavio Viera
Dr Jean-Luc Vigneron Prof Bernard Weber Dr Sabine Zenker
Catherine Decuyper Wendy Lewis
Christophe Luino
Dermatology Dermatology
Neuro-endocrinology Facial plastic surgery
COUNTRY USA
UK Italy
Aesthetic & anti-ageing medicine South Africa Netherlands Slovakia Thailand Italy
France UK
USA USA
Dermatology & Anti-ageing medicine Thailand Aesthetic surgery Plastic surgery Dermatology
Anti-ageing medicine Aesthetic dermatology Genetics
Dermatology
Ireland Spain Israel Spain
France
Luxembourg Germany
Industry expert & consultant France Industry expert
USA Industry expert & consultant France
prime-journal.com | June 2013 ❚ 5
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84